Elevated GFAP expression is likely involved in the pathogenesis of neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (Palmer and Ousman, 2018). Here, GFAP is linked to Parkinson disease.